All In MedTech

Device Trial Radar · NCT06486454

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

5,000

Planned (sponsor's estimate)

Start

Oct 14, 2024

Primary completion

Nov 2034

Study completion Nov 2039

Sponsor

Lead sponsor
HistoSonics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 3, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristics may affect histotripsy success at 36 hours post-histotripsy procedure. Sub-studies to the BOOMBOX: Master Study will investigate specific populations and/or clinical questions with more stringent enrollment criteria, standardized testing criteria, and/or follow-up schedule. Any participant enrolled in the BOOMBOX: Master Study that also qualifies for a sub-study may enroll in the sub-study in parallel; sub-studies will be described in separate sub-study protocols. The BOOMBOX: Master Study will collect information about participants before, during, and after the histotripsy treatment procedure. All participants will be followed per standard clinical follow-up based on each site's clinical practice for up to 5 years after the initial histotripsy procedure or until completion of their follow-up in a sub-study, whichever is longer.

Conditions

  • Liver Neoplasms
  • Primary Liver Cancer
  • Secondary Liver Cancer
  • Tumor Liver
  • Benign Liver Tumor

Interventions

  • HistoSonics Edison SystemDevice

    Histotripsy with the HistoSonics Edison System for the full or partial destruction of liver tumors

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Histotripsy Technical SuccessTime frame: ≤36 hours post-histotripsy treatment procedure

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • University of South Alabama

    Mobile, Alabama · Recruiting

  • Providence St. Jude

    Fullerton, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

32 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.